Estrategia diagnóstica y terapéutica dirigida a pacientes con VIH en unidades de cuidados intensivos: Revisión narrativa
Palabras clave:
VIH, Virus de la inmunodeficiencia humana, Unidad de cuidados intensivos, Cuidados críticos, Enfermedad crítica, PrognosisResumen
Desde la aparición de la terapia antirretroviral efectiva, en los últimos 20 años, la infección por el virus de inmunodeficiencia humana (VIH) se ha convertido en una enfermedad infecciosa crónica. En este contexto, el objetivo de esta revisión narrativa fue presentar un enfoque diagnostico organizado y una terapia ajustada a la condición del paciente en unidades de cuidados intensivos. Se realizó una revisión del tema mediante una búsqueda bibliográfica en bases de datos empleando los términos MeSH “intensive care”, “HIV”, “critical illness”, “human immunodeficiency virus”. Se emplearon filtros para seleccionar los artículos en idioma inglés y español. La búsqueda en diferentes bases de datos arrojó un total de 3243 resultados, y tras descartar duplicados y seleccionar por título y resumen, se obtuvieron 151 artículos. Finalmente, 46 artículos se incluyeron en esta revisión de tema, seleccionados después de revisar el texto completo. La terapia antirretroviral oportuna está demostrada que disminuye la morbilidad y mortalidad. Además, es necesario estar alerta frente a la aparición de síndrome inflamatorio de reconstitución inmune, diagnosticarlo y tratarlo. Desde su ingreso a urgencias, los pacientes deben ser evaluados completa, rigurosa y regularmente para identificar cambios clínicos, complicaciones o factores pronósticos. Mediante el inicio oportuno de una estrategia diagnóstica y terapéutica y el traslado a una unidad de cuidados intermedios o intensivos para una monitorización, los pacientes con VIH pueden obtener un manejo adecuado de la condición crítica y mejorar su pronóstico.
Descargas
Citas
Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. HIV. Lancet. 2018; 392(10148):685-97. DOI: 10.1016/S0140-6736(18)31311-4
Zaaqoq AM, Khasawneh FA, Smalligan RD. Cardiovascular Complications of HIV-Associated Immune Dysfunction. Cardiol Res Pract. 2015; 2015:302638. DOI: 10.1155/2015/302638
Huang L, Quartin A, Jones D, Havlir D V. Intensive Care of Patients with HIV Infection. N Engl J Med. 2006; 355(2):173-81. DOI: 10.1056/NEJMra050836
Sobrino-Vegas P, Moreno S, Rubio R, Viciana P, Bernardino JI, Blanco JR, et al. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013. J Infect. 2016; 72(5):587-96. DOI: 10.1016/j.jinf.2016.01.017
Akgün KM, Pisani M, Crothers K. The changing epidemiology of HIV-infected patients in the intensive care unit. J Intensive Care Med. 2011; 26(3):151-64. DOI: 10.1177/0885066610387996
Adlakha A, Pavlou M, Walker DA, Copas AJ, Dufty N, Batson S, et al. Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy. Int J STD AIDS. 2011; 22(9):498-504. DOI: 10.1258/ijsa.2011.010496
Corona A, Raimondi F. Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era. Curr HIV Res. 2009; 7(6):569-79. DOI: 10.2174/157016209789973592
Ganesan A, Masur H. Critical Care of Persons Infected with the Human Immunodeficiency Virus. Clin Chest Med. 2013; 34(2):307-23. DOI: 10.1016/j.ccm.2013.01.011
Coquet I, Pavie J, Palmer P, Barbier F, Legriel S, Mayaux J, et al. Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care. 2010; 14(3):R107. DOI: 10.1186/cc9056
Palacios R, Hidalgo A, Reina C, de la Torre M V., Márquez M, Santos J. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit. HIV Med. 2006; 7(3):193-6. DOI: 10.1111/j.1468-1293.2006.00353.x
Turtle L, Vyakernam R, Menon-Johansson A, Nelson MR, Soni N. Intensive care usage by HIV-positive patients in the HAART era. Interdiscip Perspect Infect Dis. 2011; 2011:847835. DOI: 10.1155/2011/847835
Narasimhan M, Posner AJ, DePalo VA, Mayo PH, Rosen MJ. Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest. 2004; 125(5):1800-4. DOI: 10.1378/chest.125.5.1800
Verdugo F, Pinto F, Charpentier P, Von Mühlenbrock C, Soto A, Dabanch J, et al. HIV/AIDS patients in a critical care unit. The experience of a general hospital in a developing country. Rev Chil Infectol. 2015; 32(3):294-303. DOI: 10.4067/S0716-10182015000400007
Barbier F, Roux A, Canet E, Martel-Samb P, Aegerter P, Wolff M, et al. Temporal trends in critical events complicating HIV infection: 1999-2010 multicentre cohort study in France. Intensive Care Med. 2014; 40(12):1906-15. DOI: 10.1007/s00134-014-3481-7
Álvarez Barreneche MF, Restrepo Castro CA, Hidrón Botero A, Villa Franco JP, Trompa Romero IM, Restrepo Carvajal L, et al. Hospitalization causes and outcomes in HIV patients in the late antiretroviral era in Colombia. AIDS Res Ther. 2017; 14(1):60. DOI: 10.1186/s12981-017-0186-3
Dickson SJ, Batson S, Copas AJ, Edwards SG, Singer M, Miller RF. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax. 2007; 62(11):964-8. DOI: 10.1136/thx.2006.072256
Croda J, Croda MG, Neves A, De Sousa Dos Santos S. Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med. 2009; 37(5):1605-11. DOI: 10.1097/CCM.0b013e31819da8c7
Nates JL, Nunnally M, Kleinpell R, Blosser S, Goldner J, Birriel B, et al. ICU admission, discharge, and triage guidelines: A framework to enhance clinical operations, development of institutional policies, and further research. Crit Care Med. 2016; 44(8):1553-602. DOI: 10.1097/CCM.0000000000001856
Gregory AB, Turvey SL, Bagshaw SM, Sligl WI. What determines do-not-resuscitate status in critically ill HIV-infected patients admitted to ICU? J Crit Care. 2019; 53:207-11. DOI: 10.1016/j.jcrc.2019.06.010
Masur H. Management of patients with HIV in the intensive care unit. Proc Am Thorac Soc. 2006; 3(1):96-102. DOI: 10.1513/pats.200511-122JH
Shrosbree J, Campbell LJ, Ibrahim F, Hopkins P, Vizcaychipi M, Strachan S, et al. Late HIV diagnosis is a major risk factor for intensive care unit admission in HIV-positive patients: A single centre observational cohort study. BMC Infect Dis. 2013; 13(1):23. DOI: 10.1186/1471-2334-13-23
Garland A, Roberts D, Graff L. Twenty-four-hour intensivist presence: A pilot study of effects on intensive care unit patients, families, doctors, and nurses. Am J Respir Crit Care Med. 2012; 185(7):738-43. DOI: 10.1164/rccm.201109-1734OC
Glatt AE, Chirgwin K, Landesman SH. Current concepts. Treatment of Infections Associated with Human Immunodeficiency Virus. N Engl J Med. 1988; 318(22):1439-48. DOI: 10.1056/NEJM198806023182206
Ambrose JA, Gould RB, Kurian DC, DeVoe MC, Pearlstein NB, Coppola JT, et al. Frequency of and outcome of acute coronary syndromes in patients with human immunodeficiency virus infection. Am J Cardiol. 2003; 92(3):301-3. DOI: 10.1016/s0002-9149(03)00631-3
Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, et al. Clinical Features of Acute Coronary Syndromes in Patients with Human Immunodeficiency Virus Infection. Circulation. 2004; 109(3):316-9. DOI: 10.1161/01.CIR.0000114520.38748.AA
Lugassy DM, Farmer BM, Nelson LS. Metabolic and Hepatobiliary Side Effects of Antiretroviral Therapy (ART). Emerg Med Clin North Am. 2010; 28(2):409-19. DOI: 10.1016/j.emc.2010.01.011
Ferris LJ, Jetten J, Johnstone M, Girdham E, Parsell C, Walter ZC. The Florence Nightingale effect: Organizational identification explains the peculiar link between others’ suffering and workplace functioning in the homelessness sector. Front Psychol. 2016;7:16. DOI: 10.3389/fpsyg.2016.00016
Takhar SS, Hendey GW. Orthopedic Illnesses in Patients with HIV. Emerg Med Clin North Am. 2010; 28(2):335-42. DOI: 10.1016/j.emc.2010.01.009
Sarkar P, Rasheed HF. Clinical review: Respiratory failure in HIV-infected patients - a changing picture. Crit Care. 2013; 17(3):228. DOI: 10.1186/cc12552
Everett CK, Fei MW, Huang L. Respiratory Emergencies in HIV-Infected Persons. Emerg Med Clin North Am. 2010; 28(2):283-98. DOI: 10.1016/j.emc.2010.01.014
Nirappil FJ, Maheshwari A, Andrews J, Martin GS, Esper AM, Cribbs SK. Characteristics and outcomes of HIV-1-infected patients with acute respiratory distress syndrome. J Crit Care. 2015; 30(1):60-4. DOI: 10.1016/j.jcrc.2014.10.020
Thakur KT, Boubour A, Saylor D, Das M, Bearden DR, Birbeck GL. Global HIV neurology: A comprehensive review. AIDS. 2019; 33(2):163-84. DOI: 10.1097/QAD.0000000000001796
Sonneville R, Ferrand H, Tubach F, Roy C, Bouadma L, Klein IF, et al. Neurological complications of HIV infection in critically ill patients: Clinical features and outcomes. J Infect. 2011; 62(4):301-8. DOI: 10.1016/j.jinf.2011.02.003
Ho EL, Jay CA. Altered Mental Status in HIV-Infected Patients. Emerg Med Clin North Am. 2010; 28(2):311-23. DOI: 10.1016/j.emc.2010.01.012
Japiassú AM, Amâncio RT, Mesquita EC, Medeiros DM, Bernal HB, Nunes EP, et al. Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care. 2010; 14(4):R152. DOI: 10.1186/cc9221
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017; 43(3):304-77. DOI: 10.1007/s00134-017-4683-6
Afessa B, Morales I, Weaver B. Bacteremia in hospitalized patients with human immunodeficiency virus: A prospective, cohort study. BMC Infect Dis. 2001; 1:13. DOI: 10.1186/1471-2334-1-13
Mrus JM, Braun LA, Yi MS, Linde-Zwirble WT, Johnston JA. Impact of HIV/AIDS on care and outcomes of severe sepsis. Crit Care. 2005; 9(6):R623-30. DOI: 10.1186/cc3811
Abay SM, Deribe K, Reda AA, Biadgilign S, Datiko D, Assefa T, et al. The effect of early initiation of antiretroviral therapy in TB/HIV-coinfected patients: A systematic review and meta-analysis. J Int Assoc Provid AIDS Care. 2015; 14(6):560-70. DOI: 10.1177/2325957415599210
Suffredini DA, George JM, Masur H. Management of antiretrovirals in critically ill patients: Great progress but potential pitfalls. Crit Care Med. 2018; 46(5):663-5. DOI: 10.1097/CCM.0000000000003048
Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015; 373(9):795-807. DOI: 10.1056/NEJMoa1506816
Del Mar Gutierrez M, Mateo MG, Vidal F, Domingo P. Drug safety profile of integrase strand transfer inhibitors. Expert Opin Drug Saf. 2014; 13(4):431-45.
Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, et al. Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis. N Engl J Med. 2011; 365(16):1471-81. DOI: 10.1056/NEJMoa1013911
Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, et al. Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy. N Engl J Med. 2010; 362(8):697-706. DOI: 10.1056/NEJMoa0905848
Havlir D V., Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, et al. Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis. N Engl J Med. 2011; 365(16):1482-91. DOI: 10.1056/NEJMoa1013607
Boulware DR, Meya DB, Muzoora C, Rolfes MA, Huppler Hullsiek K, Musubire A, et al. Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis. N Engl J Med. 2014; 370(26):2487-98. DOI: 10.1056/NEJMoa1312884
Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008; 8(8):516-23. DOI: 10.1016/S1473-3099(08)70184-1
Achenbach CJ, Harrington RD, Dhanireddy S, Crane HM, Casper C, Kitahata MM. Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection. Clin Infect Dis. 2012; 54(3):424-33. DOI: 10.1093/cid/cir802
Stek C, Schutz C, Blumenthal L, Thienemann F, Buyze J, Nöstlinger C, et al. Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial). JMIR Res Protoc. 2016; 5(3):e173. DOI: 10.2196/resprot.6046
Meintjes G, Stek C, Blumenthal L, Thienemann F, Schutz C, Buyze J, et al. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS. Reply. N Engl J Med. 2018; 379(20):1915-25. DOI: 10.1056/NEJMc1900116
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Salutem Scientia Spiritus
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
La Revista Salutem Scientia Spiritus usa la licencia Creative Commons de Atribución – No comercial – Sin derivar: Los textos de la revista son posibles de ser descargados en versión PDF siempre que sea reconocida la autoría y el texto no tenga modificaciones de ningún tipo.
